Rajeev Venkayya, former head of the vaccine unit at Takeda
February 3, 2022 09:34 AM EST
People

Ra­jeev Venkayya, Take­da’s long­time vac­cines chief, de­parts to lead a stealth pan­dem­ic-fo­cused biotech

Jason Mast

Editor

Ra­jeev Venkayya, the long­time head of Take­da’s vac­cine unit, is step­ping down to be­come CEO of a new com­pa­ny “fo­cused on com­bat­ing COVID-19 and fu­ture …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times